An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: Structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines
Date
2013-01-20
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Anti-cancer drugs, Triphenyltin(IV) benzoates, Triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl] benzoates, Cell lines, QSAR